NLRP3 and gout: Dapansutrile (OLT1177), a β−sulfonyl nitrile compound with oral bioavailability, inhibits NLRP3 allosterically and has shown safety and anti−inflammatory effects in gout trials (156), with ongoing investigation in heart failure (157).